FrontPage is India's Stock Market Social Network
Join 50,000+ Traders and Investors
forum

DRREDDY Share Price Discussion

Dr. Reddy's Laboratories Ltd.
NSE: DRREDDY | BSE: 500124 | ISIN: INE089A01023 | Sector: Pharmaceuticals and health care

DRREDDY Rating

4.3/5 (21 Ratings)
DRREDDY Share Price *
3,146.75 +51.75 (1.67%)
* (quote may be delayed)
Find answers to all your questions on live DRREDDY message board: Is DRREDDY buy or sell? Should I buy DRREDDY shares? Why are DRREDDY shares falling? Should I invest in DRREDDY stock?

You can also check DRREDDY share price target recommended by brokerages.

DRREDDY Discussion Forum


DRREDDY - 701684
DRREDDY
DRREDDY is just trading above VWAP on 5min HA Charts and have formed a doji during last closing. It may see some resistance at current levels. However, in my opinion we may see a fall on DRREDDY if it sustains below 3120 on hourly HA Charts.
Long/Buying
If price is sust...
Read more...
Like
reply
Reply
@sanjeev6261 • Reputation: 16

DRREDDY - chart - 701472
Drreddy likely to trade in these range buy or sell around these range with sl 1 % default my choice to go long between 2920-2880 can test 3320-60
Like
reply
Reply
@JetageMatrixSystems • Reputation: 182,194
DRREDDY APR20 3050 CE

Type
Buy
Instrument
DRREDDY APR20 3050 CE
Entry Price
₹101
Price@Trade
₹249.95
Target Price
₹355
Stop Price
₹0
Valid Till
Apr 30, 2020 3:20 AM
Status
Expired before entry
re entry
Like
reply
Reply (1)
Latest replies
TrackerBot @trackerbot
Apr 3 9:11 AM

Update
Expired before entry
Price @ Update
₹232.5
@100billionclub • Reputation: 2,152

OPTION CALL: BUY DRREDDY 3200 CE ABV 162
Like
reply
Reply (1)
Latest replies

*OPTION CALL: ONCE EXIT LONG IN DRREDDY 3200 CE AT 158*
@JetageMatrixSystems • Reputation: 182,194
J2K in DRREDDY
DRREDDY APR20 FUT
Trade entered: Buy DRREDDY APR20 FUT @3067.3 Ta...
DRREDDY APR20 FUT

Type
Buy
Instrument
DRREDDY APR20 FUT
Entry Price
₹3,120
Price@Trade
₹3,188.05
Target Price
₹4,400
Stop Price
₹2,100
Valid Till
Apr 30, 2020 3:20 AM
Status
Expired before entry
re entry
Like
reply
Reply (1)
Latest replies
TrackerBot @trackerbot
Apr 3 9:11 AM

Update
Expired before entry
Price @ Update
₹3,154.3
@JetageMatrixSystems • Reputation: 182,194
DRREDDY APR20 FUT

Type
Buy
Instrument
DRREDDY APR20 FUT
Entry Price
₹3,067.3
Price@Trade
₹3,067.3
Target Price
₹4,100
Stop Price
₹2,100  ₹3,180.85
Valid Till
Apr 30, 2020 3:20 AM
Margin
₹176,807.53 approx for 250 Qty
Status
Stoploss Hit
Exit Price
₹3,180.85
Net P&L
16.06% Profit
testing futures vs options trading ...Highest risk ....please do not follow blindly
Like
reply
Reply (4)
Latest replies
J2K @JetageMatrixSystems
Apr 3 4:52 AM

Update
Stoploss Trailed
Price @ Update
₹3,144.6
Original SL
₹2,100
New SL
₹3,138.65
J2K @JetageMatrixSystems
Apr 3 5:02 AM

Update
Stoploss Trailed
Price @ Update
₹3,169
Original SL
₹3,138.65
New SL
₹3,157.85
J2K @JetageMatrixSystems
Apr 3 5:05 AM

Update
Stoploss Trailed
Price @ Update
₹3,187.7
Original SL
₹3,157.85
New SL
₹3,180.85
TrackerBot @trackerbot
Apr 3 5:08 AM

Update
Stoploss Hit
Exit Price
₹3,180.85
@JetageMatrixSystems • Reputation: 182,194
DRREDDY APR20 3050 CE

Type
Buy
Instrument
DRREDDY APR20 3050 CE
Entry Price
₹175  ₹191
Price@Trade
₹195.2
Target Price
₹410
Stop Price
₹0  ₹224.1
Valid Till
Apr 30, 2020 3:20 AM
Margin
₹47,750 approx for 250 Qty
Status
Exited
Exit Price
₹252.3
Net P&L
32.09% Profit
testing option vs futures trading ...Highest risk ....please do not follow blindly
Like
reply
Reply (4)
Latest replies
J2K @JetageMatrixSystems
Apr 3 4:19 AM

Update
Entry Price Modified
Price @ Update
₹191
Original Entry Price
₹175
New Entry Price
₹191
TrackerBot @trackerbot
Apr 3 4:20 AM

Update
Trade Entered
Entry Price
₹191
J2K @JetageMatrixSystems
Apr 3 5:05 AM

Update
Stoploss Trailed
Price @ Update
₹224.15
Original SL
₹0
New SL
₹224.1
J2K @JetageMatrixSystems
Apr 3 5:13 AM

Update
Exited
Exit Price
₹252.3
Net P&L
32.09% Profit
@newsbot • Reputation: 2,602
Nifty falls the most in FY20 since 2008 crisis; 5 stocks buck the trend
Investors lost Rs 37.59 lakh crore of wealth during the financial year 2020, most of which was in March
Moneycontrol
Like
reply
Reply
@powerofat • Reputation: -7,411
DRREDDY

Type
Sell
Instrument
DRREDDY
Entry Price
₹3,112  ₹3,110.55
Price@Trade
₹3,109.35
Target Price
₹3,000
Stop Price
₹3,150
Valid Till
Apr 13, 2020 3:20 AM
Margin
₹3,110.55 approx for 1 Qty
Status
Exited
Exit Price
₹3,069.85
Net P&L
1.31% Profit
Like
reply
Reply (3)
Latest replies

Update
Entry Price Modified
Price @ Update
₹3,110.55
Original Entry Price
₹3,112
New Entry Price
₹3,110.55
TrackerBot @trackerbot
Apr 1 5:14 AM

Update
Trade Entered
Entry Price
₹3,110.55

Update
Exited
Exit Price
₹3,069.85
Net P&L
1.31% Profit
@avinash-HJ7gXbyvU • Reputation: 0

Holding call sell Dr.Reddys 3135-3185 stoploss 3250 tgt 2750,2560,2260
Like
reply
Reply
@powerofat • Reputation: -7,411
DRREDDY

Type
Sell
Instrument
DRREDDY
Entry Price
₹3,101  ₹3,102.35
Price@Trade
₹3,102.4
Target Price
₹3,011
Stop Price
₹3,146
Valid Till
Apr 3, 2020 3:20 AM
Margin
₹3,102.35 approx for 1 Qty
Status
Exited
Exit Price
₹3,086.6
Net P&L
0.51% Profit
Like
reply
Reply (3)
Latest replies

Update
Entry Price Modified
Price @ Update
₹3,102.35
Original Entry Price
₹3,101
New Entry Price
₹3,102.35
TrackerBot @trackerbot
Apr 1 4:42 AM

Update
Trade Entered
Entry Price
₹3,102.35

Update
Exited
Exit Price
₹3,086.6
Net P&L
0.51% Profit
@powerofat • Reputation: -7,411
DRREDDY

Type
Sell
Instrument
DRREDDY
Entry Price
₹3,101
Price@Trade
₹3,102.4
Target Price
₹3,011
Stop Price
₹3,146
Valid Till
Apr 3, 2020 3:20 AM
Margin
₹3,101 approx for 1 Qty
Status
Exited
Exit Price
₹3,085.95
Net P&L
0.49% Profit
Like
reply
Reply (2)
Latest replies
TrackerBot @trackerbot
Apr 1 4:42 AM

Update
Trade Entered
Entry Price
₹3,101

Update
Exited
Exit Price
₹3,085.95
Net P&L
0.49% Profit
@OPTIONSONLY • Reputation: -54,063
DRREDDY APR20 3300 CE

Type
Buy
Instrument
DRREDDY APR20 3300 CE
Entry Price
₹108  ₹107.2
Price@Trade
₹107
Target Price
₹180
Stop Price
₹80
Valid Till
Apr 3, 2020 3:20 AM
Status
Expired before entry
Like
reply
Reply (2)
Latest replies

Update
Entry Price Modified
Price @ Update
₹107
Original Entry Price
₹108
New Entry Price
107.2
TrackerBot @trackerbot
Apr 1 9:11 AM

Update
Expired before entry
Price @ Update
₹94
@veltca • Reputation: -1,423
DRREDDY APR20 FUT

Type
Buy
Instrument
DRREDDY APR20 FUT
Entry Price
₹3,115
Price@Trade
₹3,115
Target Price
₹3,175
Stop Price
₹3,066
Valid Till
Apr 1, 2020 3:20 AM
Margin
₹182,312.63 approx for 250 Qty
Status
Validity Over
Exit Price
₹3,110.55
Net P&L
-0.61% Loss
Like
reply
Reply (1)
Latest replies
TrackerBot @trackerbot
Apr 1 8:50 AM

Update
Validity Over
Exit Price
₹3,110.55
Net P&L
-0.61% Loss
@mohan-B1lZEEB1E • Reputation: -45,188
DRREDDY APR20 3100 PE

Type
Buy
Instrument
DRREDDY APR20 3100 PE
Entry Price
₹170
Price@Trade
₹170
Target Price
₹195
Stop Price
₹150
Valid Till
Apr 30, 2020 3:20 AM
Margin
₹42,500 approx for 250 Qty
Status
Target Achieved
Exit Price
₹195
Net P&L
14.71% Profit
Like
reply
Reply (1)
Latest replies
TrackerBot @trackerbot
Apr 1 2:53 AM

Update
Target Achieved
Exit Price
₹195
@mohan-B1lZEEB1E • Reputation: -45,188
DRREDDY APR20 2800 PE

Type
Buy
Instrument
DRREDDY APR20 2800 PE
Entry Price
₹93
Price@Trade
₹93
Target Price
₹155
Stop Price
₹55
Valid Till
Apr 30, 2020 3:20 AM
Margin
₹23,250 approx for 250 Qty
Status
Stoploss Hit
Exit Price
₹55
Net P&L
-40.86% Loss
Like
reply
Reply (1)
Latest replies
TrackerBot @trackerbot
Apr 3 7:19 AM

Update
Stoploss Hit
Exit Price
₹55
@RUDRA007 • Reputation: 2,798

DRREDDY - 694777
DRREDDY COUNTER IS TRADING AT 3100 LEVELS
ALL DIPS SHOULD BE USED TO GO LONG IN THIS COUNTER
AS PER ABCD HARMONIC PATTERN COUNTER CAN MOVE TILL LEVELS OF 3500
AS PER ELLIOT WAVE FORMATION COUNTER HAVE TENDENCY TO MOVE TILL LEVELS OF 4000-4400
VIEW GETS NEGATED BELOW 2600 LEVELS...
Read more...
Like
reply
Reply
@100billionclub • Reputation: 2,152
Billion Club in DRREDDY
CARRIED: BUY DRREDDY ABV 3001

CARRIED: ONCE EXIT LONG IN DRREDDY AT 3083 BOOK PROFIT RS 20,500 PER LOT
Like
reply
Reply
@100billionclub • Reputation: 2,152

CARRIED: BUY DRREDDY ABV 3001
Like
reply
Reply (1)
Latest replies
Billion Club @100billionclub
Mar 31 4:37 AM

CARRIED: ONCE EXIT LONG IN DRREDDY AT 3083 BOOK PROFIT RS 20,500 PER LOT
@TTA • Reputation: 43,192

*DRREDDY RS 29.52 CRS NSE BLOCK TRADE; FOR~ 100000 SHARES, AT RS 2952*
Like
reply
Reply
@TTA • Reputation: 43,192

*DRREDDY RS 16.80 CRS NSE BLOCK TRADE; FOR~ 56016 SHARES, AT RS 3000*
Like
reply
Reply
@tradehunk • Reputation: -1,969
DRREDDY APR20 FUT

Type
Sell
Instrument
DRREDDY APR20 FUT
Entry Price
₹2,991
Price@Trade
₹2,991.85
Target Price
₹2,935
Stop Price
₹3,028
Valid Till
Apr 8, 2020 3:20 AM
Margin
₹170,379.93 approx for 250 Qty
Status
Stoploss Hit
Exit Price
₹3,028
Net P&L
-5.43% Loss
Like
reply
Reply (2)
Latest replies
TrackerBot @trackerbot
Mar 30 3:51 AM

Update
Trade Entered
Entry Price
₹2,991
TrackerBot @trackerbot
Mar 30 4:02 AM

Update
Stoploss Hit
Exit Price
₹3,028
@TTA • Reputation: 43,192

*DRREDDY RS 18.83 CRS NSE BLOCK TRADE; FOR~ 62728 SHARES, AT RS 3001.80*
Like
reply
Reply
@newsbot • Reputation: 2,602
Stocks in the news: Yes Bank, Piramal Enterprises, PVR, NTPC, Lupin
Yes Bank | Piramal Enterprises | PVR | NTPC | Lupin and Sanghvi Movers are among the stocks that are in the news today.
Moneycontrol
Like
reply
Reply
@newsbot • Reputation: 2,602
Trade Setup for Friday: Top 15 things to know before Opening Bell
Key support level is placed at 8,381.22, followed by 8,120.98. If the index continues moving upward, key resistance levels to watch out for are 8,825.37 and 9,009.28.
Moneycontrol
Like
reply
Reply
DRREDDY APR20 FUT

Type
Buy
Instrument
DRREDDY APR20 FUT
Entry Price
₹2,938  ₹2,936.05
Price@Trade
₹2,940
Target Price
₹3,600
Stop Price
₹2,300
Valid Till
Apr 30, 2020 3:20 AM
Margin
₹176,832.68 approx for 250 Qty
Status
Exited
Exit Price
₹3,048
Net P&L
15.83% Profit
Like
reply
Reply (3)
Latest replies

Update
Entry Price Modified
Price @ Update
₹2,936.05
Original Entry Price
₹2,938
New Entry Price
₹2,936.05
TrackerBot @trackerbot
Mar 25 6:53 AM

Update
Trade Entered
Entry Price
₹2,936.05

Update
Exited
Exit Price
₹3,048
Net P&L
15.83% Profit
@TTA • Reputation: 43,192

*DRREDDY RS 39.48 CRS NSE BLOCK TRADE; FOR~ 139743 SHARES, AT RS 2825*
Like
reply
Reply
@TTA • Reputation: 43,192

*DR REDDY RS 14.45 CRS NSE BLOCK TRADE; FOR~ 50010 SHARES, AT RS 2890*
Like
reply
Reply
@newsbot • Reputation: 2,602
Dr Reddy’s Laboratories share price up 7% as board to consider fund raising
The share touched its 52-week high Rs 3,363.00 and 52-week low Rs 2,352.00 on 20 February, 2020 and 14 August, 2019, respectively.
Moneycontrol
Like
reply
Reply
@newsbot • Reputation: 2,602
Stocks in the news: SBI, Sterlite Tech, Dr Reddy's Labs, Usha Martin, GNFC
SBI | Indiabulls Housing Finance | Usha Martin | Amber Enterprises | GNFC and Sterlite Technologies are among the stocks that are in the news today.
Moneycontrol
Like
reply
Reply
@newsbot • Reputation: 2,602
Trade Setup for Tuesday: Top 14 things to know before Opening Bell
Key support level for Nifty is placed at 7,409.48, followed by 7,208.72. If the index moves up, key resistance levels to watch out for are 7,985.13 and 8,360.02.
Moneycontrol
Like
reply
Reply
@mohan-B1lZEEB1E • Reputation: -45,188
DRREDDY MAR20 3000 CE

Type
Buy
Instrument
DRREDDY MAR20 3000 CE
Entry Price
₹24
Price@Trade
₹24
Target Price
₹52
Stop Price
₹2
Valid Till
Mar 26, 2020 3:20 AM
Margin
₹6,000 approx for 250 Qty
Status
Exited
Exit Price
₹29.2
Net P&L
21.67% Profit
Like
reply
Reply (1)
Latest replies
mohan @mohan-B1lZEEB1E
Mar 23 8:17 AM

Update
Exited
Exit Price
₹29.2
Net P&L
21.67% Profit
@TTA • Reputation: 43,192

*DR REDDY RS 15.47 CRS NSE BLOCK TRADE; FOR~ 55654 SHARES, AT RS 2779.60*
Like
reply
Reply
@TTA • Reputation: 43,192

*DR REDDY RS 54.05 CRS NSE BLOCK TRADE; FOR~ 194864 SHARES, AT RS 2773.65*
Like
reply
Reply
@mohan-B1lZEEB1E • Reputation: -45,188
DRREDDY MAR20 3000 CE

Type
Buy
Instrument
DRREDDY MAR20 3000 CE
Entry Price
₹41.5
Price@Trade
₹41.5
Target Price
₹90
Stop Price
₹10
Valid Till
Mar 26, 2020 3:20 AM
Margin
₹10,375 approx for 250 Qty
Status
Stoploss Hit
Exit Price
₹10
Net P&L
-75.9% Loss
Like
reply
Reply (1)
Latest replies
TrackerBot @trackerbot
Mar 25 5:20 AM

Update
Stoploss Hit
Exit Price
₹10
@mohan-B1lZEEB1E • Reputation: -45,188
DRREDDY MAR20 3100 CE

Type
Buy
Instrument
DRREDDY MAR20 3100 CE
Entry Price
₹25
Price@Trade
₹25
Target Price
₹55
Stop Price
₹10
Valid Till
Mar 26, 2020 3:20 AM
Margin
₹6,250 approx for 250 Qty
Status
Stoploss Hit
Exit Price
₹5
Net P&L
-80% Loss
Like
reply
Reply (1)
Latest replies
TrackerBot @trackerbot
Mar 25 3:03 AM

Update
Stoploss Hit
Exit Price
₹5
@mohan-B1lZEEB1E • Reputation: -45,188
DRREDDY MAR20 3000 CE

Type
Buy
Instrument
DRREDDY MAR20 3000 CE
Entry Price
₹41.05
Price@Trade
₹41.05
Target Price
₹85
Stop Price
₹15
Valid Till
Mar 26, 2020 3:20 AM
Margin
₹10,262.5 approx for 250 Qty
Status
Stoploss Hit
Exit Price
₹15
Net P&L
-63.46% Loss
Like
reply
Reply (1)
Latest replies
TrackerBot @trackerbot
Mar 25 3:36 AM

Update
Stoploss Hit
Exit Price
₹15
@OPTIONSONLY • Reputation: -54,063
DRREDDY APR20 FUT

Type
Buy
Instrument
DRREDDY APR20 FUT
Entry Price
₹2,752
Price@Trade
₹2,751.75
Target Price
₹2,950
Stop Price
₹2,600
Valid Till
Mar 27, 2020 3:20 AM
Margin
₹131,905.25 approx for 250 Qty
Status
Exited
Exit Price
₹2,892
Net P&L
26.53% Profit
Like
reply
Reply (2)
Latest replies
TrackerBot @trackerbot
Mar 20 4:26 AM

Update
Trade Entered
Entry Price
₹2,752

Update
Exited
Exit Price
₹2,892
Net P&L
26.53% Profit

DRREDDY - 660740
Performance for the WEEK*
*Drreddy ce3100* cmp 95.85 buy upto 50.00 stop 30.00 target 144/180.00+
Entry 65 cmp 69
Like
reply
Reply
@newsbot • Reputation: 2,602
Hot Stocks: Deploy some capital in market if Nifty trades in 9,500–9,000 range
The zone of 9,500–9,000 could act as strong support for the markets from here. If this support is held in the coming sessions, then we are of the opinion that some stability is likely to return to the markets.
Moneycontrol
Like
reply
Reply

DRREDDY - 651355
Due to heavy tanking of markets all trades were not feasable. Posting revised levels for rest of the week*
Drreddy ce3100* cmp 95.85 buy upto 50.00 stop 30.00 target 144/180.00+
Like
reply
Reply
@newsbot • Reputation: 2,602
Pharma sales see rebound in February on back of respiratory drugs
Eight of the top 10 therapies registered a growth of more than 10 percent.
Moneycontrol
Like
reply
Reply
DRREDDY MAR20 FUT

Type
Buy
Instrument
DRREDDY MAR20 FUT
Entry Price
₹3,110
Price@Trade
₹3,115.5
Target Price
₹3,400
Stop Price
₹3,000
Valid Till
Mar 26, 2020 3:20 AM
Margin
₹142,679.55 approx for 250 Qty
Status
Stoploss Hit
Exit Price
₹3,000
Net P&L
-19.27% Loss
Like
reply
Reply (2)
Latest replies
TrackerBot @trackerbot
Mar 9 3:26 AM

Update
Trade Entered
Entry Price
₹3,110
TrackerBot @trackerbot
Mar 11 7:27 AM

Update
Stoploss Hit
Exit Price
₹3,000
@ripulgupta • Reputation: 2,550
DRREDDY MAR20 FUT

Type
Buy
Instrument
DRREDDY MAR20 FUT
Entry Price
₹3,156.5
Price@Trade
₹3,156.5
Target Price
₹3,300
Stop Price
₹3,100
Valid Till
Mar 9, 2020 3:20 AM
Margin
₹143,652.55 approx for 250 Qty
Status
Stoploss Hit
Exit Price
₹3,100
Net P&L
-9.83% Loss
Like
reply
Reply (1)
Latest replies
TrackerBot @trackerbot
Mar 9 3:27 AM

Update
Stoploss Hit
Exit Price
₹3,100
@stocktrendr • Reputation: 193

Citi on Dr Reddy’s
Maintained ‘Buy’ with a price target of Rs 3,700.
Like
reply
Reply

Futures & Options educational trades for the week 9.3.20 to 13.3.20*
(My trade rules apply)
*ALL TRADES SUBJECT TO CORONA PANIC*
#stockmarket
Drreddy ce3200* cmp 91.85 buy upto 50.00 stop 30.00 target 144/180.00+
Like
reply
Reply
@100billionclub • Reputation: 2,152

CARRIED: SELL DRREDDY MAR BELOW 3153
Like
reply
Reply (1)
Latest replies

ONCE BOOK AND EXIT SHORT IN DRREDDY AS SL HIT AT 3195
@Trend • Reputation: 1,105
Super Trend in DRREDDY
BUY DRREDDY MARCH CMP 3215 TARGETS 3228-3235 💢D...

DRREDDY HIGH ✔️✔️✔️3233.25✔️✔️
Like
reply
Reply
@Trend • Reputation: 1,105
Super Trend in DRREDDY
BUY DRREDDY MARCH CMP 3215 TARGETS 3228-3235 💢D...

DRREDDY HIT ✔️✔️1ST TARGET 3228✔️✔️✔️
Like
reply
Reply
  • DRREDDY - Share Price - Fundamentals

    keyboard_arrow_down
    Market Capitalization46,050.89
    Enterprise Value46,829.69
    Price to Earnings61.08
    Price to Book Value3.63
    Return on Capital Employed0.05
    Return on Equity0.05
    Face Value5
    Dividend Yield0.01
  • DRREDDY Share Price - Technicals

    keyboard_arrow_down
    DRREDDY - 52 Week High₹3,364.95
    DRREDDY - 52 Week Low₹2,351.2
  • DRREDDY - Brokerage Reports

    keyboard_arrow_down
    DateBrokerageCallTarget
    29-Jan-20HDFC SecuritiesNeutral3,440
    29-Jan-20Karvy Stock BrokingHold3,378
    29-Jan-20ICICIdirect.comHold3,255
    28-Jan-20Prabhudas LilladherAccumulate3,331
    12-Nov-19Geojit Financial ServicesHold2,961
    DRREDDY Brokerage Price Target
  • DRREDDY Share Price - Historical (₹)

    keyboard_arrow_down
    DateOpenHighLowClose
    Apr 330853218.853025.13146.8
    Apr 13119.95314430663095
    Mar 31305031523032.053120.75
    Mar 302879.6305028112994.25
    Mar 272952.83046.952846.12916.5
  • DRREDDY Share Price - Daily Moving Averages (DMA)

    keyboard_arrow_down
    20 Day Moving Average₹2,936.04
    30 Day Moving Average₹3,014.06
    50 Day Moving Average₹3,069.15
    100 Day Moving Average₹2,973.2
    200 Day Moving Average₹2,809.41
  • DRREDDY - Profit And Loss

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Revenue9,3599,719.8-0.04
    Operating Profit1,3301,745.6-0.24
    Profit Before Tax6971,544.5-0.55
    Net Income5661,384.1-0.59
  • DRREDDY - Balance Sheet

    keyboard_arrow_down
    CONSOLIDATEDMar-19Mar-18 % Change
    Shareholder's Funds12,68411,8070.07
    Total Liabilities3,5645,545-0.36
    Total Assets16,24817,353-0.06
  • DRREDDY - Cash Flow

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Cash from Operating Activity1,5381,015.90.51
    Cash from Investing Activity-1,1801,430.5-1.82
    Cash from Financing Activity-304-2,581.8-0.88
    Net Cash Flow54-135.4-1.4
  • DRREDDY - Ratios

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17
    Return on Assets0.030.08
    Return on Equity0.050.12
    Return on Capital Employed0.050.11
  • DRREDDY - 3 year Growth

    keyboard_arrow_down
    3 Year CAGR Growth in Revenue-0.07
    3 Year CAGR Growth in Operating Profit-0.44
    3 Year CAGR Growth in EBIDTA-0.41
    3 Year CAGR Growth in Net Income-0.66
    3 Yr CAGR Growth - Diluted EPS-0.65
  • DRREDDY - 5 year Growth

    keyboard_arrow_down
    5 Year CAGR Growth in Revenue0.12
    5 Year CAGR Growth in Operating Profit-0.33
    5 Year CAGR Growth in EBIDTA-0.28
    5 Year CAGR Growth in Net Income-0.55
    3 Yr CAGR Growth - Diluted EPS-0.54
  • DRREDDY - Recent News

    keyboard_arrow_down
    NewsBot
    Apr 1 9:43 AM
    Nifty falls the most in FY20 since 2008 crisis; 5 stocks buck the trend
    Moneycontrol
    NewsBot
    Mar 27 1:08 AM
    Stocks in the news: Yes Bank, Piramal Enterprises, PVR, NTPC, Lupin
    Moneycontrol
    NewsBot
    Mar 26 2:28 AM
    Trade Setup for Friday: Top 15 things to know before Opening Bell
    Moneycontrol
    NewsBot
    Mar 24 6:08 AM
    Dr Reddy’s Laboratories share price up 7% as board to consider fund raising
    Moneycontrol
    NewsBot
    Mar 24 1:13 AM
    Stocks in the news: SBI, Sterlite Tech, Dr Reddy's Labs, Usha Martin, GNFC
    Moneycontrol
    NewsBot
    Mar 23 2:58 AM
    Trade Setup for Tuesday: Top 14 things to know before Opening Bell
    Moneycontrol
    NewsBot
    Mar 13 12:38 PM
    Hot Stocks: Deploy some capital in market if Nifty trades in 9,500–9,000 range
    Moneycontrol
    NewsBot
    Mar 9 2:23 AM
    Pharma sales see rebound in February on back of respiratory drugs
    Moneycontrol
    NewsBot
    Mar 4 10:43 AM
    Taking Stock: Sharp rise in coronavirus cases drag market; Sensex sees 946 pts swing intraday
    Moneycontrol
    NewsBot
    Feb 28 11:13 AM
    Dr Reddy's gets 2 observations from USFDA for formulation plant
    Moneycontrol
  • DRREDDY - Related Communities

    keyboard_arrow_down
    Sun Pharmaceutical Industries Ltd. S...
    Aurobindo Pharma Ltd. Sector: Pharma...
    Biocon Ltd. Sector: Pharmaceuticals ...
    Cipla Ltd. Sector: Pharmaceuticals a...
    Lupin Ltd. Sector: Pharmaceuticals an...
    Piramal Enterprises Ltd. Sector: Phar...
    Divi's Laboratories Ltd. Sector: Pha...
    Glenmark Pharmaceuticals Ltd. Sector...
    Strides Pharma Science Ltd. Sector: P...
    Apollo Hospitals Enterprise Ltd. Sec...
  • DRREDDY - More Information

    keyboard_arrow_down

    Dr Reddy's Laboratories Ltd:
    Dr Reddy's Laboratories Limited has been acquiring a worldwide recognition in the pharmaceutical market for the last three decades. The company is running its operation through three core segments viz. Pharmaceutical Services and Active Ingredients (PSAI), Global Generics and Proprietary Products.
    Active pharmaceutical ingredients are manufactured and marketed by this PSAI segment. These are the essential ingredients for finished pharmaceutical products. In the basis of specific customer requirements, the company is providing active pharmaceutical ingredients and steroids. The Proprietary Product segment refers to the research and development procedures of the firm. Along with that, these segments deals with manufacturing and selling dermatological and neurological therapeutic issues.
    The company deals with several therapeutic issues such as respiratory, cardiovascular, respiratory, anti-diabetic, urology, gastrointestinal, nephrology, oncology and stomatology. The company has strong business-relation with Curis Inc. regarding the research, development and marketing of small molecules for precision oncology and precision oncology. Having its head office at Hyderabad in India, Dr Reddy's Laboratories Limited was founded in 1984.
    About Company Information:
    Soon after its establishment with an initial investment of Rs.25 lacs, the company started the manufacturing of Active Pharmaceutical Ingredients and Intermediates in a 60-tonne manufacturing plant near Hyderabad, India. The Bombay Stock Exchange enlisted the company in 1986. USDA approval for manufacturing Ibuprofen was given to the company for the first time in the year of 1987.
    For developing and expanding the market and production of Bulk Actives, the company acquired Benzex Laboratories Pvt Ltd in 1988. Norfloxacin and Ciprofloxacin were started to be exported by the company from 1990 mostly in Europe and East, just a year before commencing formulation exports to Russia in 1991. Dr Reddy's Research Foundation was inaugurated by the company in 1993.
    In 1995, the company had gone for a joint venture in Russia. Company's first ANDA was filled with United States Food and Drug Administration for manufacturing Ranitidine in 1997. India-based pharmaceutical company American Remedies Ltd was acquired by the firm in 1999.
    The company turned to be the third-largest pharmaceutical organization in India in 2000 when a merger took place between the company and Cheminor Drugs Ltd. Fluoxetine capsules were introduced by the company in 2001.
    The company commenced their debut acquisition in abroad when it acquired Meridian Healthcare and BMS Laboratories Limited at the UK in 2002. Ibuprofen was launched as the first generic under Dr Reddy's label at US market in 2003. Roche's API manufacturing business at Mexico was acquired by the company in 2005 just a year back of buying Germany's fourth-largest generic company Betapharm against an amount of Rs.480 million in 2006. Plant's first biosimilar MAb, for treating Non-Hodgkins Lymphoma was introduced by Dr Reddy's Laboratories Limited in 2007.
    A cent per cent subsidiary of the company with a 'Special Economic Zone' facility namely, Dr Reddys Pharma SEZ Ltd was established during 2009-10. At the same period, an amalgamation with Perlecan Pharma Pvt Ltd took place. The oral penicillin manufacturing plant of Glaxo Smith Kline at Tennessee in the USA was acquired by the company during 2010-11.
    US Federal Trade Commission issued an order of consent on November 2014, allowing the acquisition of Novartis Consumer Health Inc.'s Habitrol brand by Dr Reddy's Laboratories Limited which was finally announced officially by Dr Reddy's Laboratories in December 2014.
    A warning letter was issued from US Food and Drug Administration accusing Dr Reddys Laboratories Limited regarding the API manufacturing plants of the firm at Miryalaguda, Telangana and Andhra's Srikakulam along with the manufacturing facility of Oncology Formulation at Vishakhapatnam, Andhra Pradesh on November 2015. The company started to intervene in the market of Colombia with premium quality cancer medicines at affordable prices in October of 2016.
    The manufacturing, research, future development and commercialization of DFD-06, a topical steroid with enormous potential, had been out-licensed to Encore Dermatology Inc. by Promius Pharma, LLC, a cent per cent owned subsidiary of Dr Reddys Laboratories Ltd in the August of 2017.
    How Dr Reddy's Laboratories Ltd, is categorised as a Pharmaceuticals and Healthcare Sector, and Pharmaceutical Industry :
    The Pharmaceutical Industry includes companies that derive their business by researching, discovering, developing, manufacturing, and marketing and distributing pharmaceutical medicines and drugs.
    Dr Reddy's Laboratories Ltd is categorized under the Pharmaceutical and Health care sector and Pharmaceutical Industry. Healthcare sectors consist of firms involved in the medical space. It is one of the multiple sectors that comprise a range of businesses, including ones that offer medical services directly, or to those that work to develop, create and market medical equipment and medicines. It also includes the other services that provide medical insurance and other related products, and many more.
    The stocks of health care companies mostly have mixed performance. It is due to the inherent challenges to the industry each year, regulatory uncertainties, fiscal policy concerns, and more.
    Dr Reddy's Laboratories Ltd, Competitors and Sector Peers:
    Abbott India Ltd. ABBIND
    Alembic Ltd. ALELTD
    Alembic Pharmaceuticals Ltd. ALEPHA
    Alkem Laboratories Ltd. ALKLAB
    Alpa Laboratories Ltd. ALPLAB
    Ambalal Sarabhai Enterprises Ltd. AMBSAR
    AstraZeneca Pharma India Ltd. ASTZEN
    Bafna Pharmaceuticals Ltd. BAFPHA
    Bajaj Healthcare Ltd. BAJHEA
    Biocon Ltd. BIOLTD
    Cian Healthcare Ltd.
    Cipla Ltd. CIPLTD
    Concord Drugs Ltd. CONDRU
    Dishman Pharmaceuticals & Chemicals Ltd.[Merged] DISPHA
    Divi's Laboratories Ltd. DIVIL
    Dr. Reddy's Laboratories Ltd. DR
    GlaxoSmithKline Pharmaceuticals Ltd. GLAPHA
    Glenmark Pharmaceuticals Ltd. GLEPHL
    IOL Chemicals and Pharmaceuticals Ltd. IOLCHE
    Lincoln Pharmaceuticals Ltd. LINPHA
    Lupin Ltd. LUPLTD
    Madhuveer Com 18 Network Ltd. TOHPHA
    Mahavir Advanced Remedies Ltd. INDAME
    Makers Laboratories Ltd. MAKLAB
    Natco Pharma Ltd. NATPHA
    Natural Capsules Ltd. NATCAP
    Ranbaxy Laboratories Ltd. RANLAB
    Sanofi India Ltd. AVEPHA
    Sharon Bio-Medicine Ltd. SHAPHA
    Sun Pharmaceutical Industries Ltd. SUN28
    Zenith Healthcare Ltd. ZENHEA
    Zyden Gentec Ltd. ZYDGEN
SOURCE: Data from D'Market via Quandl. Intraday data delayed 15 minutes.
DISCLAIMER: Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and FrontPage will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein.